Phospholipid levels in blood during community-acquired pneumonia
Open Access
- 7 May 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (5) , e0216379
Abstract
Phospholipids, major constituents of bilayer cell membranes, are present in large amounts in pulmonary surfactant and play key roles in cell signaling. Here, we aim at finding clinically useful disease markers in community-acquired pneumonia (CAP) using comprehensive phospholipid profiling in blood and modeling of changes between sampling time points. Serum samples from 33 patients hospitalized with CAP were collected at admission, three hours after the start of intravenous antibiotics, Day 1 (at 12–24 h), Day 2 (at 36–48 h), and several weeks after recovery. A profile of 75 phospholipid species including quantification of the bioactive lysophosphatidylcholines (LPCs) was determined using liquid chromatography coupled to time-of-flight mass spectrometry. To control for possible enzymatic degradation of LPCs, serum autotaxin levels were examined. Twenty-two of the 33 patients with a clinical diagnosis of CAP received a laboratory-verified CAP diagnosis by microbial culture or microbial DNA detection by qPCR. All major phospholipid species, especially the LPCs, were pronouncedly decreased in the acute stage of illness. Total and individual LPC concentrations increased shortly after the initiation of antibiotic treatment, concentrations were at their lowest 3h after the initiation, and increased after Day 1. The total LPC concentration increased by a change ratio of 1.6–1.7 between acute illness and Day 2, and by a ratio of 3.7 between acute illness and full disease resolution. Autotaxin levels were low in acute illness and showed little changes over time, contradicting a hypothesis of enzymatic degradation causing the low levels of LPCs. In this sample of patients with CAP, the results demonstrate that LPC concentration changes in serum of patients with CAP closely mirrored the early transition from acute illness to recovery after the initiation of antibiotics. LPCs should be further explored as potential disease stage biomarkers in CAP and for their potential physiological role during recovery.Keywords
Funding Information
- Vetenskapsrådet (Support of MIMS, Umeå University)
- Västerbotten Läns Landsting (VLL-402201, VLL-322921, VLL-495291)
- Kempestiftelserna (SMK-1353)
This publication has 31 references indexed in Scilit:
- Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK PhosphorylationPLOS ONE, 2013
- Shorthand notation for lipid structures derived from mass spectrometryJournal of Lipid Research, 2013
- HMDB 3.0—The Human Metabolome Database in 2013Nucleic Acids Research, 2012
- Metabolic consequences of sepsis-induced acute lung injury revealed by plasma1H-nuclear magnetic resonance quantitative metabolomics and computational analysisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Factors associated with inflammatory cytokine patterns in community-acquired pneumoniaEuropean Respiratory Journal, 2010
- Lysophosphatidic acid signaling in airway epithelium: Role in airway inflammation and remodelingCellular Signalling, 2009
- Trypanosoma cruziInfection Is Enhanced by Vector Saliva through Immunosuppressant Mechanisms Mediated by LysophosphatidylcholineInfection and Immunity, 2008
- Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Lipid signalling in diseaseNature Reviews Molecular Cell Biology, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008